| Item Type | Name |
|
Concept
|
B-Lymphocytes
|
|
Concept
|
Bone Marrow Cells
|
|
Concept
|
HeLa Cells
|
|
Concept
|
Receptors, Antigen, B-Cell
|
|
Concept
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
|
Concept
|
Stromal Cells
|
|
Concept
|
3T3 Cells
|
|
Concept
|
Endothelial Cells
|
|
Concept
|
Tumor Cells, Cultured
|
|
Concept
|
Cells, Cultured
|
|
Academic Article
|
Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells.
|
|
Academic Article
|
Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia.
|
|
Academic Article
|
Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia.
|
|
Academic Article
|
Critical signal transduction pathways in CLL.
|
|
Academic Article
|
Tris (dibenzylideneacetone) dipalladium: a small-molecule palladium complex is effective in inducing apoptosis in chronic lymphocytic leukemia B-cells.
|
|
Academic Article
|
Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia.
|
|
Academic Article
|
Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.
|
|
Academic Article
|
The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy.
|
|
Academic Article
|
HSP90 overexpression potentiates the B-cell receptor and fibroblast growth factor receptor survival signals in chronic lymphocytic leukemia cells.
|
|
Academic Article
|
Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia.
|
|
Academic Article
|
Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG.
|
|
Academic Article
|
Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression.
|
|
Academic Article
|
Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors.
|
|
Academic Article
|
Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy.
|
|
Grant
|
Microvesicle Dynamics in B-Cell Chronic Lymphocytic Leukemia Tumor Microenvironme
|
|
Academic Article
|
Upregulation of AXL and ß-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistance.
|
|
Academic Article
|
SIRT3 overexpression and epigenetic silencing of catalase regulate ROS accumulation in CLL cells activating AXL signaling axis.
|
|
Academic Article
|
Tumor-suppressive effects of MBP-1 in non-small cell lung cancer cells.
|
|
Academic Article
|
Knockdown of MBP-1 in human foreskin fibroblasts induces p53-p21 dependent senescence.
|
|
Academic Article
|
Inhibition of hepatitis C virus protein expression by RNA interference.
|
|
Academic Article
|
Distinct functional role of Hepatitis C virus core protein on NF-kappaB regulation is linked to genomic variation.
|
|
Academic Article
|
Ebola virus glycoprotein-mediated anoikis of primary human cardiac microvascular endothelial cells.
|
|
Academic Article
|
Knockdown of MBP-1 in human prostate cancer cells delays cell cycle progression.
|
|
Academic Article
|
Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice.
|
|
Academic Article
|
MBP-1 mediated apoptosis involves cytochrome c release from mitochondria.
|
|
Academic Article
|
Idelalisib activates AKT via increased recruitment of PI3Kd/PI3Kß to BCR signalosome while reducing PDK1 in post-therapy CLL cells.
|